Updated On: 12 October, 2021 08:41 AM IST | Mumbai | Somita Pal
An analysis by SevenHills doctors shows that the average hospital stay was eight days for patients given the cocktail therapy and far more for others

Drug includes two monoclonal antibodies, Casirivimab and Imdevimab, that mimic the action of natural antibodies. Representation pic
The cocktail therapy, touted as the miracle treatment for COVID-19, considerably reduces hospital stay and recovery, shows a data analysed by SevenHills Hospital, which is one of the biggest BMC-run COVID-19 facilities.
The data analysis, which is part of a larger study by the doctors at SevenHills, includes 506 COVID-19 patients who were given monoclonal antibody cocktail. Till date, more than 810 patients have received the cocktail therapy at SevenHills.